The report "Spine
Biologics Market by Product Type (Bone Graft, Bine Graft Substitute, Platelet
Rich Plasma, BMAC), Surgery Type (Anterior Cervical Discectomy and Fusion,
Posterior Lumbar Interbody Fusion), End User, and Geography - Global Forecast
to 2020", the global spine biologics market was valued at $1.90
Billion in 2014 and is expected to reach $2.4 Billion by 2020, at a CAGR of
4.4% during the forecast period of 2015 to 2020.
Browse 55 market data tables and 54 figures spread through 101 pages and in-depth TOC on "Spine Biologics Market"
will receive 10% customization on this report.
The global spine biologics market is anticipated to register
a significant growth due to extensive usage of bone grafts substitutes, rising
aging population, and increasing preference amongst surgeons.
Spine biologics are used in spine surgery as lieu allografts
and as support for bones in and around the spinal region. They can also be used
as products that can cure the spine injuries or disorders or degenerated discs.
They stimulate the process of bone growth and spinal fusion and offer various
advantages, such as minimal postoperative pain, shorter hospital stays, faster
recovery, in addition to eliminating the need of harvesting bone from patient.
Unlike metals, which are inert in nature, biologics activate cellular growth by
stimulating spine fusion. This market constituted 33.5% share of the global
spinal implants and spinal devices market.
Talk To Our Research Analyst for More Info@
The preferred usage of spine biologics among surgeons has led to an
increased demand of products that are based on this technique. Furthermore, the
rise in aging population, obesity, and demand for minimally invasive procedure
has led to increased demand for spine biologics. Increase in healthcare
expenditure in Asian region (and globally) has also contributed to the growth
of spinal biologics market to a certain extent.
The North American spine biologics market contributed the largest share in the global market, and was dominated largely by the U.S. Europe is the second-largest market for spine biologics with Germany leading the market in the region. The limitations of the global spine biologics market are stringent regulatory guidelines, which make approvals a costly affair; and lack of awareness coupled with high cost of the surgeries. Major companies operational in the spine biologics market are Medtronic Inc. (U.S.), DePuy Synthes Companies (U.S.), Zimmer Holding Inc. (U.S.), Nuvasive Inc. (U.S.), Stryker Corporation (U.S.), Orthofix International N.V. (U.S.), K2M Inc. (U.S.), Exactech Inc. (U.S.), Wright Medical Technology Inc. (U.S.), and others.
Get the Customized Information@
The research study is aimed at
identifying emerging trends and opportunities in the global spine biologics
market along with detailed classifications, in terms of revenue. It provides
comprehensive competitive landscape and identifies the key players with respect
to market size and market share. The research study also includes a detailed
segmentation of the global spine biologics market on the basis of product type,
surgery type, and geography.
Apart from the market segmentation,
this report also provides an in-depth analysis of the market by providing a
detailed process flow diagram and market dynamics, such as drivers, restraints,
and opportunities in the global spine biologics market.
Browse Related Reports:
Spinal Implants and Spinal Devices Market by Product (Thoracic, Lumbar, Cervical Fusion, Biologics, Motion Preservation, VCFs, Bone Stimulator), Technologies, Minimally Invasive Device, Decompression (Laminectomy, Corpectomy) - Global Forecast to 2020.
Biosurgery Market by Type (Surgical Sealants, Hemostatic Agents, Soft Tissue Attachments, Adhesion Barriers, Bone Graft Substitutes), Application (Neurological, Cardiovascular, General, Orthopedic, Reconstructive) - Global Forecast to 2020.
is the world’s No. 2 firm in terms of annually published premium market
research reports. Serving 1700 global fortune enterprises with more than 1200
premium studies in a year, M&M is catering to a multitude of clients across
8 different industrial verticals. We specialize in consulting assignments and
business research across high growth markets, cutting edge technologies and
newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are
tracking global high growth markets following the "Growth Engagement Model
– GEM". The GEM aims at proactive collaboration with the clients to
identify new opportunities, identify most important customers, write
"Attack, avoid and defend" strategies, identify sources of
incremental revenues for both the company and its competitors.
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche markets.
The new included chapters on Methodology and Benchmarking presented with high
quality analytical infographics in our reports gives complete visibility of how
the numbers have been arrived and defend the accuracy of the numbers.
MarketsandMarkets are inspired to help our clients grow by providing apt
business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http:/www.marketsandmarkets.com/Subscription.html
Unit No. 802, 8th Floor,
Tower - 7, Magarpatta City SEZ,
Hadapsar, Pune – 411013,
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets